The relationship between cardiovascular dysfunction and renal impairment is widely recognized as the cardiorenal interaction, a complex physiological link in which damage to one organ can accelerate deterioration in the other. This interdependence has gained increasing attention in recent years, particularly with the emergence of therapies such as sodium-glucose cotransporter-2 inhibitors, which have demonstrated protective effects for both the heart and kidneys.
This article was originally published on MedicalXpress.com
